SCHEMBL626189

SCHEMBL626189

CS(=O)(=O)N1CCC(Nc2nn3c(Cl)c(-c4cnc(N)c(C(F)(F)F)c4)nc3s2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K12 Q12852 1/20 0.42
CDK2 P24941 17/20 0.41
CCNE1 P24864 14/20 0.41
CDK1 P06493 13/20 0.41
CCND1 P24385 12/20 0.41
CDK4 P11802 11/20 0.41
CCNB1 P14635 10/20 0.41
CDK6 Q00534 9/20 0.41
CCND3 P30281 8/20 0.41
CCNT1 O60563 2/20 0.40
CDK7 P50613 2/20 0.40
CDK9 P50750 2/20 0.40
CCNH P51946 2/20 0.40
MNAT1 P51948 2/20 0.40
PIK3CA P42336 2/20 0.39
CCNB2 O95067 1/20 0.38
CCNE2 O96020 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625109 0.91 CDK2 (0.46) MAP3K12CDK2CCNE1CDK1CCND1
SCHEMBL626188 0.89 MAP3K12 (0.41) MAP3K12CDK2CCNE1CDK1CCND1
SCHEMBL625108 0.86 CDK2 (0.42) MAP3K12CDK2CCNE1CDK1CCND1
SCHEMBL626206 0.86 PIK3CA (0.53) MAP3K12PIK3CA
SCHEMBL627467 0.86 HASPIN (0.43) MAP3K12CCNT1PIK3CA
SCHEMBL627322 0.85 FYN (0.48) MAP3K12PIK3CA
SCHEMBL626795 0.84 PIK3CA (0.41) MAP3K12PIK3CA
SCHEMBL626207 0.83 MAP3K12 (0.46) MAP3K12CDK2CCNE1CDK1CCND1
SCHEMBL628258 0.81 DPP4 (0.38) PIK3CA
SCHEMBL625753 0.77 PIK3CA (0.49) MAP3K12PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed